Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R0GK
|
|||
| Former ID |
DIB003482
|
|||
| Drug Name |
NU300
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 2 | [1] | |
| Company |
Nuron biotech
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Haemophilus influenzae CRM197 (Hae-influ CRM197) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01732198) A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02140047) Exploratory Clinical Study of MT-2301. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.